Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
603113.SS Stock Summary
In the News
603113.SS Financial details
Company Rating
Strong Buy
Market Cap
5.89B
Income
-5.15M
Revenue
13.61B
Book val./share
10.34
Cash/share
2.26
Dividend
0.12
Dividend %
1.49%
Employees
2.89K
Optionable
No
Shortable
Yes
Earnings
27 Apr 2024
P/E
-1301.37
Forward P/E
5.26
PEG
133.34
P/S
0.5
P/B
0.78
P/C
2.98
P/FCF
-5.47
Quick Ratio
0.72
Current Ratio
1
Debt / Equity
0.57
LT Debt / Equity
0.21
-
-
EPS (TTM)
0.03
EPS next Y
1.28
EPS next Q
-
EPS this Y
-73.87%
EPS next Y
4694.01%
EPS next 5Y
4694.01%
EPS last 5Y
-31.19%
Revenue last 5Y
13.78%
Revenue Q/Q
-1.96%
EPS Q/Q
-10.71%
-
-
-
-
SMA20
-
SMA50
-12.5%
SMA100
-12.5%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-0.01%
Gross Margin
1%
Oper. Margin
-1%
Profit Margin
-
Payout
-2612%
Shs Outstand
840.81M
Shs Float
413.25M
-
-
-
-
Target Price
-
52W Range
5.51-10.43
52W High
-32.7%
52W Low
+34.6%
RSI
38
Rel Volume
0.58
Avg Volume
7.04M
Volume
4.09M
Perf Week
-5.21%
Perf Month
6.32%
Perf Quarter
-
Perf Half Y
-20.07%
-
-
-
-
Beta
0.961
-
-
Volatility
0.19%, 0.15%
Prev Close
1.82%
Price
6.73
Change
-0.15%
603113.SS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 13.04 | 12.08 | 9.08 | 13.07 | 19.81 | |
Net income per share | 1.88 | 1.13 | 1.07 | 1.01 | 0.29 | |
Operating cash flow per share | 2.5 | 0.72 | 1.59 | 0.9 | -0.6 | |
Free cash flow per share | 1.36 | -1.3 | -1.29 | -0.67 | -2.67 | |
Cash per share | 1.42 | 2.03 | 2.28 | 2.18 | 3.55 | |
Book value per share | 7.2 | 8.74 | 9.7 | 9.55 | 10.27 | |
Tangible book value per share | 6 | 7.52 | 8.58 | 8.48 | 9.09 | |
Share holders equity per share | 7.2 | 8.74 | 9.7 | 9.55 | 10.27 | |
Interest debt per share | 0.35 | 1.82 | 1.77 | 2.44 | 5.82 | |
Market cap | 7.36B | 7.28B | 13.59B | 14.94B | 7.69B | |
Enterprise value | 6.65B | 8.19B | 14.73B | 16.19B | 10.8B | |
P/E ratio | 5.8 | 9.55 | 15.28 | 16.14 | 30.87 | |
Price to sales ratio | 0.84 | 0.89 | 1.8 | 1.25 | 0.46 | |
POCF ratio | 4.35 | 14.94 | 10.27 | 18.16 | -15.01 | |
PFCF ratio | 8 | -8.3 | -12.65 | -24.31 | -3.4 | |
P/B Ratio | 1.51 | 1.24 | 1.69 | 1.71 | 0.88 | |
PTB ratio | 1.51 | 1.24 | 1.69 | 1.71 | 0.88 | |
EV to sales | 0.75 | 1 | 1.95 | 1.35 | 0.64 | |
Enterprise value over EBITDA | 3.58 | 6.58 | 9.23 | 8.95 | 9.89 | |
EV to operating cash flow | 3.93 | 16.8 | 11.13 | 19.68 | -21.07 | |
EV to free cash flow | 7.23 | -9.34 | -13.71 | -26.35 | -4.77 | |
Earnings yield | 0.17 | 0.1 | 0.07 | 0.06 | 0.03 | |
Free cash flow yield | 0.13 | -0.12 | -0.08 | -0.04 | -0.29 | |
Debt to equity | 0.05 | 0.21 | 0.18 | 0.25 | 0.55 | |
Debt to assets | 0.03 | 0.14 | 0.12 | 0.17 | 0.3 | |
Net debt to EBITDA | -0.38 | 0.73 | 0.72 | 0.69 | 2.85 | |
Current ratio | 2.25 | 2.97 | 1.58 | 1.54 | 1.13 | |
Interest coverage | 103.47 | 118.72 | 106.28 | 26.68 | 2.87 | |
Income quality | 1.33 | 0.64 | 1.49 | 0.88 | -2.06 | |
Dividend Yield | 0.02 | 0.04 | 0 | 0.02 | 0.05 | |
Payout ratio | 0.09 | 0.34 | 0.02 | 0.35 | 1.42 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0.01 | 0 | |
Research and developement to revenue | 0 | 0 | 0.01 | 0.01 | 0.01 | |
Intangibles to total assets | 0.12 | 0.09 | 0.08 | 0.07 | 0.06 | |
Capex to operating cash flow | -0.46 | -2.8 | -1.81 | -1.75 | 3.42 | |
Capex to revenue | -0.09 | -0.17 | -0.32 | -0.12 | -0.1 | |
Capex to depreciation | -2.48 | -4 | -5.47 | -2.77 | -2.32 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 17.45 | 14.9 | 15.28 | 14.73 | 8.24 | |
ROIC | 0.25 | 0.1 | 0.09 | 0.08 | 0.03 | |
Return on tangible assets | 0.21 | 0.1 | 0.08 | 0.08 | 0.02 | |
Graham Net | -0.06 | -0.57 | -1.14 | -0.94 | -2.23 | |
Working capital | 1.93B | 2.58B | 1.68B | 1.77B | 806.93M | |
Tangible asset value | 4.06B | 5.07B | 7.13B | 7.78B | 7.71B | |
Net current asset value | 1.55B | 1.11B | 552.65M | 690.91M | -464.55M | |
Invested capital | 0.05 | 0.21 | 0.18 | 0.25 | 0.55 | |
Average receivables | 893.14M | 917.19M | 1.08B | 1.22B | 2.1B | |
Average payables | 686.15M | 815.26M | 1.3B | 1.56B | 1.33B | |
Average inventory | 537.51M | 559.84M | 556.72M | 848.25M | 1.08B | |
Days sales outstanding | 35.89 | 43.35 | 57.56 | 37.93 | 64.32 | |
Days payables outstanding | 37.31 | 48.38 | 99.08 | 51.06 | 27.31 | |
Days of inventory on hand | 29 | 29.83 | 32.23 | 40.69 | 22.69 | |
Receivables turnover | 10.17 | 8.42 | 6.34 | 9.62 | 5.67 | |
Payables turnover | 9.78 | 7.54 | 3.68 | 7.15 | 13.36 | |
Inventory turnover | 12.58 | 12.23 | 11.33 | 8.97 | 16.09 | |
ROE | 0.26 | 0.13 | 0.11 | 0.11 | 0.03 | |
Capex per share | -1.14 | -2.02 | -2.89 | -1.57 | -2.06 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 5.53 | 3.23 | 3.22 | 4.45 | 4.44 | |
Net income per share | 0.09 | -0.01 | -0.13 | 0.09 | 0.08 | |
Operating cash flow per share | 0.09 | -0.01 | -0.13 | 0.25 | 0.89 | |
Free cash flow per share | -0.86 | -0.31 | -0.82 | -0.6 | 0.49 | |
Cash per share | 3.57 | 3.59 | 3 | 2.86 | 2.26 | |
Book value per share | 9.13 | 10.4 | 8.03 | 10.18 | 10.34 | |
Tangible book value per share | 8.11 | 9.21 | 7.1 | 9.02 | 9.04 | |
Share holders equity per share | 9.13 | 10.4 | 8.03 | 10.18 | 10.34 | |
Interest debt per share | 2.71 | 5.83 | 5.33 | 5.99 | 5.99 | |
Market cap | 8.88B | 7.59B | 10.62B | 6.86B | 6.97B | |
Enterprise value | 9.56B | 10.7B | 13.39B | 9.5B | 10.03B | |
P/E ratio | 25.91 | -175.54 | -19.13 | 22.06 | 26.13 | |
Price to sales ratio | 1.68 | 2.81 | 3.09 | 1.82 | 1.88 | |
POCF ratio | 103.63 | -702.14 | -76.54 | 32.94 | 9.39 | |
PFCF ratio | -10.81 | -29.13 | -12.15 | -13.41 | 17.03 | |
P/B Ratio | 1.02 | 0.87 | 1.24 | 0.79 | 0.81 | |
PTB ratio | 1.02 | 0.87 | 1.24 | 0.79 | 0.81 | |
EV to sales | 1.81 | 3.96 | 3.89 | 2.52 | 2.71 | |
Enterprise value over EBITDA | 299.29 | 169.15 | -84.68 | 107.45 | 85.33 | |
EV to operating cash flow | 111.5 | -989.82 | -96.53 | 45.63 | 13.52 | |
EV to free cash flow | -11.63 | -41.07 | -15.33 | -18.58 | 24.52 | |
Earnings yield | 0.01 | 0 | -0.01 | 0.01 | 0.01 | |
Free cash flow yield | -0.09 | -0.03 | -0.08 | -0.07 | 0.06 | |
Debt to equity | 0.3 | 0.55 | 0.66 | 0.59 | 0.57 | |
Debt to assets | 0.16 | 0.3 | 0.33 | 0.29 | 0.29 | |
Net debt to EBITDA | 21.14 | 49.16 | -17.54 | 29.88 | 26.07 | |
Current ratio | 1.25 | 1.13 | 1.14 | 1.07 | 1 | |
Interest coverage | 3.3 | -1.43 | -5.49 | 2.84 | 1.47 | |
Income quality | 1 | 1 | 1 | 2.68 | 11.13 | |
Dividend Yield | 0.04 | 0 | 0 | 0 | 0.02 | |
Payout ratio | 3.78 | -1.49 | -0.08 | 0.03 | 1.58 | |
Sales general and administrative to revenue | 0.03 | -0.04 | 0.01 | -0.01 | 0.03 | |
Research and developement to revenue | 0.03 | -0.06 | 0.01 | 0.01 | 0.01 | |
Intangibles to total assets | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | |
Capex to operating cash flow | -10.59 | 23.1 | 5.3 | -3.46 | -0.45 | |
Capex to revenue | -0.17 | -0.09 | -0.21 | -0.19 | -0.09 | |
Capex to depreciation | -4.63 | -1.27 | -3.89 | -3.81 | 0.88 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 4.29 | 1.74 | 4.85 | 4.58 | 4.31 | |
ROIC | 0 | 0 | -0.01 | 0.01 | 0 | |
Return on tangible assets | 0.01 | 0 | -0.01 | 0 | 0 | |
Graham Net | -1.47 | -2.26 | -2.24 | -3.58 | -4.48 | |
Working capital | 1.5B | 806.93M | 935.63M | 485.73M | -31.82M | |
Tangible asset value | 7.75B | 7.71B | 7.57B | 7.65B | 7.54B | |
Net current asset value | 281.48M | -464.55M | -991.84M | -1.49B | -2.12B | |
Invested capital | 0.3 | 0.55 | 0.66 | 0.59 | 0.57 | |
Average receivables | 1.8B | 2.47B | 3.1B | 3.29B | 3.07B | |
Average payables | 3.46B | 2.33B | 1.24B | 1.5B | 1.86B | |
Average inventory | 1.64B | 1.42B | 981.15M | 1.13B | 1.49B | |
Days sales outstanding | 33.76 | 98.71 | 84.87 | 79.58 | 68.27 | |
Days payables outstanding | 61.16 | 39.45 | 32.51 | 42.15 | 51.4 | |
Days of inventory on hand | 32.48 | 32.77 | 24.45 | 32.11 | 42.97 | |
Receivables turnover | 2.67 | 0.91 | 1.06 | 1.13 | 1.32 | |
Payables turnover | 1.47 | 2.28 | 2.77 | 2.14 | 1.75 | |
Inventory turnover | 2.77 | 2.75 | 3.68 | 2.8 | 2.09 | |
ROE | 0.01 | 0 | -0.02 | 0.01 | 0.01 | |
Capex per share | -0.95 | -0.3 | -0.69 | -0.85 | -0.4 |
603113.SS Frequently Asked Questions
What is Jinneng Science & Technology Co., Ltd. stock symbol ?
Jinneng Science & Technology Co., Ltd. is a CN stock and trading under the symbol 603113.SS
What is Jinneng Science & Technology Co., Ltd. stock quote today ?
Jinneng Science & Technology Co., Ltd. stock price is $6.73 today.
Is Jinneng Science & Technology Co., Ltd. stock public?
Yes, Jinneng Science & Technology Co., Ltd. is a publicly traded company.